Insigna, Inc. — Form D/A
Insigna, Inc. of CHAMPAIGN, IL, a company, filed a Form D amendment with the SEC on 2023-03-10. $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-03-10
- Form: D/A
- Accession: 0001780356-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $1.2M
- Minimum investment: $5K
- Investors: 7
- Date of first sale: 2022-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-468766
Issuer
- Name: Insigna, Inc.
- CIK: 0001780356
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2109 S. Oak St, Suite 100A, CHAMPAIGN, IL, 61820
- Phone: 833-565-4771
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Byron Alexandrovich Wittenberg | Director | Champaign, IL |
| Byron Alexandrovich Wittenberg | Executive Officer | Champaign, IL |
| CheMyong Jay Ko | Director | Champaign, IL |
| CheMyong Jay Ko | Executive Officer | Champaign, IL |
Other filings by this issuer (5)
More